Edition:
United States

Insider Trading: Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

1.90USD
2 Dec 2016
Change (% chg)

-- (--)
Prev Close
$1.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,900
52-wk High
$24.00
52-wk Low
$1.76

DP VII ASSOCIATES L P

Institutional Holders

% Shares Owned: 57.89%
# of Holders: 74
Total Shares Held: 8,444,467
3 Mo. Net Change: 421,748
# New Positions: 12
# Closed Positions: 31
# Increased Positions: 26
# Reduced Positions: 52
# Net Buyers: -26

Officers & Directors

Name Age Since Current Position

Michael Narachi

56 2016 President, Chief Executive Officer, Director

Jason Keyes

2016 Chief Financial Officer, Senior Vice President

Thomas Cannell

54 2016 Chief Operating Officer, Executive Vice President, President - Global Commercial Products

Thomas Lynch

2015 Executive Vice President, General Counsel, Secretary

Peter Flynn

2016 Senior Vice President, Head - Development, Regulatory Affairs and Safety

Toni Foster

2016 Senior Vice President - Project Management Office and Clinical Operations

Chris Hazuka

2015 Acting General Counsel

Louis Bock

50 2005 Independent Director

Brian Dovey

74 2004 Independent Director

David Endicott

50 2012 Independent Director

Peter Honig

58 2010 Independent Director

Debora Jorn

58 2016 Independent Director

Patrick Mahaffy

53 2009 Independent Director

Lota Zoth

56 2012 Independent Director